Neurocrine Biosciences shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $29M | 203k | 140.38 |
| 2025-03-31 | $20M | 179k | 110.60 |
| 2024-12-31 | $27M | 195k | 136.50 |
| 2024-03-31 | $2.3M | 17k | 137.92 |
| 2023-12-31 | $29M | 220k | 131.76 |
| 2023-09-30 | $59M | 528k | 112.50 |
| 2023-06-30 | $78M | 825k | 94.30 |
| 2021-12-31 | $27M | 321k | 85.17 |
| 2021-09-30 | $15M | 159k | 95.91 |
| 2020-06-30 | $348k | 2.9k | 121.85 |
| 2019-09-30 | $31M | 343k | 90.11 |
| 2019-03-31 | $8.8M | 99k | 88.10 |
| 2018-09-30 | $20M | 164k | 122.95 |
| 2018-06-30 | $32M | 328k | 98.24 |
| 2018-03-31 | $19M | 234k | 82.93 |
| 2017-12-31 | $28M | 362k | 77.59 |
| 2017-09-30 | $37M | 603k | 61.28 |
| 2017-03-31 | $600k | 14k | 43.30 |
| 2016-09-30 | $3.2M | 63k | 50.65 |
| 2015-12-31 | $5.4M | 96k | 56.57 |
| 2015-09-30 | $8.2M | 205k | 39.79 |
| 2015-06-30 | $2.9M | 60k | 47.77 |